Why One Analyst Thinks ASML Is Worth $1,971

Bernstein raised its ASML price target to $1,971 (from $1,911), keeping an Outperform and naming it its EU Semis top pick; the stock is already up 91% over the past year and 16% YTD. Bernstein’s thesis centers on DRAM-driven EUV demand (ASML EUV revenue +39% YoY to $13.47B in 2025; Q4 2025 orders $15.28B including $8.60B in EUV; backlog $45.06B) and ASML’s 2030 revenue target of €44–€60B plus a €12B buyback and a 17% dividend raise. Key execution risks are hitting 2026 revenue guidance ($39.49B–$45.30B), continued EUV memory shipments, and offsetting China revenue declines (China = $11.06B, 29.1% of 2025 sales) amid export controls; reaching $1,971 implies a market cap >$750B versus current ~$547.3B.

Analysis

The immediate second-order winner is not just the ASML franchise but the narrow set of upstream suppliers and integration services that scale EUV throughput: precision optics, high-peak-power lasers, and field-installation engineering capacity. If memory customers front-load capacity, expect multi-quarter supply chokepoints in those niches that can bottleneck ASML revenue conversion even if order books remain intact — that creates a non-linear cadence to earnings where booking strength does not map 1:1 to near-term free cash flow.

Policy and cycle risk sits on two orthogonal axes. A tighter export regime or a single large customer pause would compress consensus upside quickly within weeks, whereas a memory down-cycle or efficiency improvements in AI training would erode demand over 12–36 months; watch quarterly order conversion rates and announced fab start dates as the leading indicators. Concurrently, increasing revenue concentration into one product (EUV) magnifies margin leverage but also makes ASML more sensitive to any single-component supplier disruption or software/yield step-back.

Valuation upside to a bold target is feasible through a combination of earnings growth and multiple expansion, but the asymmetry favors option-like exposure rather than outright leverage: the path to a materially higher market cap requires both sustained DRAM capex cycles and continued exclusion from China sales; either element failing would rapidly repriced. For portfolio construction, treat ASML as a strategic technology call tied to an idiosyncratic policy risk bucket rather than a pure growth secular name — size positions to withstand headline-driven 20–30% drawdowns while capturing multi-quarter convexity if EUV throughput accelerates.

Key Decisions for Investors

• Bullish, limited-risk options: Buy ASML Jan-2027 call spread (debit) sized at 2–4% of equity allocation — buy calls ~30% OTM / sell calls ~90% OTM; holds 12–24 months to capture EUV conversion and derisk if two consecutive quarters show order-to-revenue slippage. R/R: capped upside but <100% downside limited to premium; target 2x+ if EUV ramp sustains.
• Directional equity pair: Long ASML spot / short KLAC equal notional for 12 months — rationale is to isolate EUV-specific upside versus metrology cyclicality. Exit/trim rules: unwind pair if ASML underperforms KLA by >10% on sequential quarters or if export controls materially widen (sell signal).
• Hedge for policy tail: Buy 6–12 month puts ~20–30% OTM to hedge headline export-control risk if position size >3% of book; alternatively, purchase a put calendar (near-term put + longer-term put) to protect against rapid policy shocks while keeping upside exposure.
• Selective supplier plays: Allocate a tactical, small overweight to pure-play optics/laser suppliers and high-touch services vendors that can reprice/scale quickly (size 0.5–1% each) with 9–18 month horizon — these names will rerate ahead of ASML if bottlenecks bind. Exit on signs of capacity relief (new supplier capacity announcements) or if ASML reports sustained, smooth order-to-revenue conversion.